Growth and Nutritional Status of Very Low Birth Weight Infants Fed a High Protein Exclusive Human Milk Diet
Status: | Not yet recruiting |
---|---|
Conditions: | Women's Studies |
Therapuetic Areas: | Reproductive |
Healthy: | No |
Age Range: | Any |
Updated: | 2/20/2019 |
Start Date: | March 1, 2019 |
End Date: | March 31, 2020 |
Contact: | Amy Gates, RD |
Email: | amgates@augusta.edu |
Phone: | 706-721-1084 |
The purpose of this two-arm investigation is to determine if growth patterns of very low
birth weight infants (VLBW) (birth weight 750-1500 grams) fed human milk (maternal or donor)
supplemented with a human milk-based fortifier grow according to established guidelines and
maintain adequate micronutrient levels.
birth weight infants (VLBW) (birth weight 750-1500 grams) fed human milk (maternal or donor)
supplemented with a human milk-based fortifier grow according to established guidelines and
maintain adequate micronutrient levels.
To achieve this goal, the investigators will prospectively analyze the growth and
micronutrient status of VLBW infants who are fed human milk (maternal or donor) supplemented
with a human-milk-based fortifier with increased protein (Medolac® Human Milk Fortifier). In
addition, the investigators will compare the findings to retrospectively collected data for
growth rates and micronutrient status of infants who received human milk fortified with cow's
milk -based fortifier (Enfamil® Hydrolyzed Liquid Human Milk Fortifier). The investigators
hypothesize that a human milk-based fortifier with increased protein will support growth at
recommended levels (weight gain of 12-18 g/kg/day, head circumference 0.75-1.0 cm/week,
length 0.8-1.1 cm/week)[1-3] and prevent micronutrient deficiency in the VLBW infant
Aim 1: To determine if VLBW infants fed human milk, maternal or donor, supplemented with a
human milk-based fortifier with increased protein grow at recommended levels for weight,
length, and head circumference. To achieve this aim, Z-scores for weight, length, and head
circumference will be tracked. Measurements will be taken at birth and then weekly until 36
weeks post-menstrual age (PMA) or discharge from the neonatal intensive care unit (NICU),
whichever comes first. Aim 2: To measure nutritional status in VLBW premature infants fed
human milk supplemented with a human milk-based fortifier with increased protein. To achieve
this aim, serum magnesium, potassium, chloride, blood urea nitrogen (BUN), creatinine,
sodium, calcium, phosphorus, CO2, Vitamin D 1, 25 (OH) 2D, parathyroid hormone (PTH),
alkaline phosphatase, hemoglobin, hematocrit will be measured within 24 hours of reaching
full enteral feedings and repeated seven days later, and then every fourteen days until 36
weeks PMA or discharge, whichever comes first. Urine magnesium and sodium will be measured on
the same schedule.
Aim 3: To compare growth rates and nutritional status of VLBW infants fed human milk
fortified with a human milk-based fortifier to growth rates and nutritional status of those
fed human milk fortified with a cow's milk-based fortifier.
micronutrient status of VLBW infants who are fed human milk (maternal or donor) supplemented
with a human-milk-based fortifier with increased protein (Medolac® Human Milk Fortifier). In
addition, the investigators will compare the findings to retrospectively collected data for
growth rates and micronutrient status of infants who received human milk fortified with cow's
milk -based fortifier (Enfamil® Hydrolyzed Liquid Human Milk Fortifier). The investigators
hypothesize that a human milk-based fortifier with increased protein will support growth at
recommended levels (weight gain of 12-18 g/kg/day, head circumference 0.75-1.0 cm/week,
length 0.8-1.1 cm/week)[1-3] and prevent micronutrient deficiency in the VLBW infant
Aim 1: To determine if VLBW infants fed human milk, maternal or donor, supplemented with a
human milk-based fortifier with increased protein grow at recommended levels for weight,
length, and head circumference. To achieve this aim, Z-scores for weight, length, and head
circumference will be tracked. Measurements will be taken at birth and then weekly until 36
weeks post-menstrual age (PMA) or discharge from the neonatal intensive care unit (NICU),
whichever comes first. Aim 2: To measure nutritional status in VLBW premature infants fed
human milk supplemented with a human milk-based fortifier with increased protein. To achieve
this aim, serum magnesium, potassium, chloride, blood urea nitrogen (BUN), creatinine,
sodium, calcium, phosphorus, CO2, Vitamin D 1, 25 (OH) 2D, parathyroid hormone (PTH),
alkaline phosphatase, hemoglobin, hematocrit will be measured within 24 hours of reaching
full enteral feedings and repeated seven days later, and then every fourteen days until 36
weeks PMA or discharge, whichever comes first. Urine magnesium and sodium will be measured on
the same schedule.
Aim 3: To compare growth rates and nutritional status of VLBW infants fed human milk
fortified with a human milk-based fortifier to growth rates and nutritional status of those
fed human milk fortified with a cow's milk-based fortifier.
Inclusion Criteria:
1. Birth weight 750-1500 grams
2. Admitted to AU NICU within 24 hours of life
3. Estimated gestational age (EGA) 23 to 33 weeks as confirmed by the Ballard score
4. Birth weight appropriate for gestational age (AGA) defined as >3rd% on a
gender-specific Fenton growth curve (Fenton 2013, Calgary, Canada)
5. Enteral feedings initiated within 7 days of life
6. Breastmilk diet, maternal or donor milk
Exclusion Criteria:
1. Renal conditions affecting electrolyte metabolism and/or excretion
2. Gastro-intestinal conditions that preclude feeding or affect nutrient absorption
(gastroschisis, omphalocele)
3. EGA >33 weeks or birth weight >1500 grams or EGA <23 weeks or birth weight <750 grams
4. Apgar <3 at 5 minutes
5. Grade 3 or higher intraventricular hemorrhage (IVH)
6. Intrauterine growth restriction (IUGR), as defined as <3rd% on a gender-specific
Fenton growth curve
7. Congenital anomalies including congenital heart disease or other major defect
requiring surgical intervention
8. Intake of cow's milk formula or fortifier before or after the initiation of the study
protocol
We found this trial at
1
site
Click here to add this to my saved trials